Perspective: Pharmas Looking to Socialytics for Improved Market Intelligence

IDC
April 12, 2012
3 Pages - SKU: IDC3860705
EyeCyte, Inc. - Product Pipeline Review - 2014
8/25/2014 | published by: Global Markets Direct
EyeCyte, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘EyeCyte, Inc. - Product Pipeline Review - 2014’, provides an overview of the EyeCyte, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
China Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
China Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential. However,  |  read more...
USD 1,295
Estonia Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
Estonia Pharmaceuticals and Healthcare Report - Q4 2014 BMI View: Against a backdrop of GDP contraction in Q114, Estonian pharmacy sales posted considerablegrowth, driven by demand for over-the-counter medicines and an uptick in prescriptions written.  |  read more...
USD 1,295
Business Strategy - Complaint Boxes in the Time of Government Watchdogs and Social Media — What Is the Impact on Banking?
9/1/2014 | published by: IDC
Business Strategy: Complaint Boxes in the Time of Government Watchdogs and Social Media — What Is the Impact on Banking? This IDC Financial Insights report discusses how, with the formation of the Consumer Finance Protection Bureau  |  read more...
USD 4,500
SomaGenics Inc. - Product Pipeline Review - 2014
8/31/2014 | published by: Global Markets Direct
SomaGenics Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘SomaGenics Inc. - Product Pipeline Review - 2014’, provides an overview of the SomaGenics Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Pharmaceuticals and Healthcare Report - Hong Kong Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Hong Kong Q4 2014 BMI View: Hong Kong will remain as an attractive destination for foreign pharmaceutical firms due torising medical demands from the ageing population. In addition, its proximity from  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Japan Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Japan Q4 2014 BMI View: The weak Japanese yen, coupled with biennial medicine price cuts, will negatively impactmultinational pharmaceutical firms operating in Japan. With effect from April 1 2014, consumption tax  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Namibia Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - Namibia Q4 2014 BMI View: There are signs the Namibian government is taking the ongoing problem related to drugshortages and supply issues seriously, with the Tender Board of Namibia approving a  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
Colombia Pharmaceuticals and Healthcare - Report Q4 2014 BMI View: President Juan Manuel Santos' re-election in June has given him a strong mandate to continuethe process of healthcare reform in Colombia. Although the Santos administration has  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Korea Q4 2014
8/27/2014 | published by: Business Monitor International
Pharmaceuticals and Healthcare Report - South Korea Q4 2014 BMI View: South Korea's pharmaceutical market will continue to grow in low-single digit terms due to thegovernment's aim to contain healthcare expenditure in general and pharmaceuticalcosts in  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!